M. Atlantique and . Loire, Vendée and Finistère from the Ligue Nationale contre le Cancer, to EBC (2013?2014); by a grant from the Cancéropôle Grand Ouest and Région Pays de la Loire, to SH (2015?2016); by a grant from the Cancéropôle Grand Ouest and Région Centre, to EP); by NIH P50GM085273 to BW; and awards from the Gillson-Longenbaugh Foundation to RP and WA. This work has been funded, in part, by a UNM Cancer Center Support Grant (P30 CA118100) to RP and WA. The INCa financed the salary of DF, The study was supported by grant number 2010-088 from Institut National du Cancer (INCa), to SH and EBC the Cancéropôle Grand Ouest and Région Pays de la Loire financed the salary of AB (HII-GO project) and the Academic Science Education and Research Training-Institutional Research and Academic Career Development Award (ASERT IRACDA, grant number NIGMS K12 GM088021) supported the salary of Alfreda, pp.2015-2016, 2010.

R. Kyle, Monoclonal gammopathy of undetermined significance, The American Journal of Medicine, vol.64, issue.5, pp.814-826, 1978.
DOI : 10.1016/0002-9343(78)90522-3

URL : https://hal.archives-ouvertes.fr/hal-00945713

M. Dhodapkar, MGUS to myeloma: a mysterious gammopathy of underexplored significance, Blood, vol.128, issue.23, pp.2599-2606, 2016.
DOI : 10.1182/blood-2016-09-692954

R. Kyle and P. Greipp, Smoldering Multiple Myeloma, New England Journal of Medicine, vol.302, issue.24, pp.1347-1349, 1980.
DOI : 10.1056/NEJM198006123022405

URL : https://hal.archives-ouvertes.fr/hal-00557757

S. Rajkumar, International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma, The Lancet Oncology, vol.15, issue.12, pp.538-548, 2014.
DOI : 10.1016/S1470-2045(14)70442-5

E. Drouet, Oligo-monoclonal immunoglobulins frequently develop during concurrent cytomegalovirus (CMV) and Epstein-Barr virus (EBV) infections in patients after renal transplantation, Clinical and Experimental Immunology, vol.377, issue.3, pp.465-472, 1999.
DOI : 10.1002/(SICI)1096-9071(199904)57:4<383::AID-JMV10>3.0.CO;2-3

URL : https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1905451/pdf

N. Babel, F. Schwarzmann, A. Pruss, H. Volk, and P. Reinke, Monoclonal gammopathy of undetermined significance (MGUS) is associated with an increased frequency of Epstein-Barr Virus (EBV) latently infected B lymphocytes in long-term renal transplant patients, Transplantation Proceedings, vol.36, issue.9, pp.2679-2682, 2004.
DOI : 10.1016/j.transproceed.2004.09.046

S. Rajkumar, R. Kyle, M. Plevak, J. Murray, and T. Therneau, Helicobacter pylori infection and monoclonal gammopathy of undetermined significance, British Journal of Haematology, vol.31, issue.3, pp.706-708, 2002.
DOI : 10.1056/NEJM199510123331508

URL : http://onlinelibrary.wiley.com/doi/10.1046/j.1365-2141.2002.03912.x/pdf

M. Plummer, C. De-martel, J. Vignat, J. Ferlay, F. Bray et al., Global burden of cancers attributable to infections in 2012: a synthetic analysis, The Lancet Global Health, vol.4, issue.9, pp.609-616, 2016.
DOI : 10.1016/S2214-109X(16)30143-7

M. Seifert, R. Scholtysik, and R. Küppers, Origin and Pathogenesis of B Cell Lymphomas, Methods Mol Biol, vol.971, pp.1-25, 2013.
DOI : 10.1007/978-1-62703-269-8_1

S. Franceschi, Infection with Hepatitis B and C Viruses and Risk of Lymphoid Malignancies in the European Prospective Investigation into Cancer and Nutrition (EPIC), Cancer Epidemiology Biomarkers & Prevention, vol.20, issue.1, pp.208-214, 2011.
DOI : 10.1158/1055-9965.EPI-10-0889

URL : https://hal.archives-ouvertes.fr/hal-00811971

A. Saha and E. Robertson, Epstein-Barr Virus-Associated B-cell Lymphomas: Pathogenesis and Clinical Outcomes, Clinical Cancer Research, vol.17, issue.10, pp.3056-3063, 2011.
DOI : 10.1158/1078-0432.CCR-10-2578

URL : http://clincancerres.aacrjournals.org/content/clincanres/17/10/3056.full.pdf

S. Hermouet, I. Corre, M. Gassin, E. Bigot-corbel, C. Sutton et al., Hepatitis C Virus, Human Herpesvirus 8, and the Development of Plasma-Cell Leukemia, New England Journal of Medicine, vol.348, issue.2, pp.178-179, 2003.
DOI : 10.1056/NEJM200301093480219

E. Bigot-corbel, M. Gassin, I. Corre, L. Carrer, D. Delaroche et al., Hepatitis C virus (HCV) infection, monoclonal immunoglobulin specific for HCV core protein, and plasma-cell malignancy, Blood, vol.112, issue.10, pp.4357-4358, 2008.
DOI : 10.1182/blood-2008-07-167569

URL : http://www.bloodjournal.org/content/bloodjournal/112/10/4357.full.pdf

S. Panfilio, Regression of a case of Multiple Myeloma with antiviral treatment in a patient with chronic HCV infection, Leukemia Research Reports, vol.2, issue.1, pp.39-40, 2013.
DOI : 10.1016/j.lrr.2013.01.002

D. Feron, Multiplexed infectious protein microarray immunoassay suitable for the study of the specificity of monoclonal immunoglobulins, Analytical Biochemistry, vol.433, issue.2, pp.202-209, 2013.
DOI : 10.1016/j.ab.2012.10.012

URL : https://hal.archives-ouvertes.fr/inserm-01401584

E. Komatsu, Characterization of immunoglobulins through analysis of N-glycopeptides by MALDI-TOF MS, Methods, vol.104, pp.170-181, 2016.
DOI : 10.1016/j.ymeth.2016.01.005

G. Xu, Viral immunology Comprehensive serological profiling of human populations using a synthetic human virome, Science, vol.348, issue.6239, p.698, 2015.

P. Mintz, Fingerprinting the circulating repertoire of antibodies from cancer patients, Nature Biotechnology, vol.4, issue.1, pp.57-63, 2003.
DOI : 10.1002/pros.2990210521

C. Seidel, M. Børset, I. Turesson, N. Abildgaard, A. Sundan et al., Elevated serum concentrations of hepatocyte growth factor in patients with multiple myeloma. The Nordic Myeloma Study Group, Blood, vol.91, issue.3, pp.806-812, 1998.

T. Iwasaki, T. Hamano, A. Ogata, N. Hashimoto, M. Kitano et al., Clinical significance of vascular endothelial growth factor and hepatocyte growth factor in multiple myeloma, British Journal of Haematology, vol.324, issue.4, pp.796-802, 2002.
DOI : 10.1074/jbc.271.2.603

A. Jurczyszyn, Play a Significant Role in the Progression of Multiple Myeloma, Journal of Cancer, vol.5, issue.7, pp.518-524, 2014.
DOI : 10.7150/jca.9266

X. Wang, Inflammatory markers and development of symptom burden in patients with multiple myeloma during autoloinsight .jci.org https

G. Brias, S. Stack, G. Stacey, M. Redwood, A. Humphreys et al., The role of IL-22 in viral infections: paradigms and paradoxes, Front Immunol, vol.7, p.211, 2016.

G. Sonnenberg, L. Fouser, and D. Artis, Border patrol: regulation of immunity, inflammation and tissue homeostasis at barrier surfaces by IL-22, Nature Immunology, vol.148, issue.5, pp.383-390, 2011.
DOI : 10.1164/ajrccm/148.6_Pt_1.1523

E. Stephen-victor, H. Fickenscher, and J. Bayry, IL-26: An Emerging Proinflammatory Member of the IL-10 Cytokine Family with Multifaceted Actions in Antiviral, Antimicrobial, and Autoimmune Responses, PLOS Pathogens, vol.24, issue.et al., p.1005624, 2016.
DOI : 10.1371/journal.ppat.1005624.g002

URL : https://hal.archives-ouvertes.fr/hal-01340570

F. Liew, J. Girard, and H. Turnquist, Interleukin-33 in health and disease, Nature Reviews Immunology, vol.2013, issue.11, pp.676-689, 2016.
DOI : 10.1186/ar4143

T. Therneau, Incidence of Monoclonal Gammopathy of Undetermined Significance and Estimation of Duration Before First Clinical Recognition, Mayo Clinic Proceedings, vol.87, issue.11, pp.1071-1079, 2012.
DOI : 10.1016/j.mayocp.2012.06.014

L. Boise, J. Kaufman, N. Bahlis, S. Lonial, and K. Lee, The Tao of myeloma, Blood, vol.124, issue.12, pp.1873-1879, 2014.
DOI : 10.1182/blood-2014-05-578732

S. Hermouet, Qualitative and quantitative analysis of human herpesviruses in chronic and acute B cell lymphocytic leukemia and in multiple myeloma, Leukemia, vol.15, issue.1, pp.185-195, 2003.
DOI : 10.1038/sj.leu.2402049

S. Gauld, D. Porto, J. Cambier, and J. , B Cell Antigen Receptor Signaling: Roles in Cell Development and Disease, Science, vol.296, issue.5573, pp.1641-1642, 2002.
DOI : 10.1126/science.1071546

N. Scrima, J. Lepault, Y. Boulard, D. Pasdeloup, S. Bressanelli et al., Insights into Herpesvirus Tegument Organization from Structural Analyses of the 970 Central Residues of HSV-1 UL36 Protein, Journal of Biological Chemistry, vol.73, issue.14, pp.8820-8833, 2015.
DOI : 10.1128/JVI.00971-14

URL : https://hal.archives-ouvertes.fr/hal-01448263

S. Rigaud, XIAP deficiency in humans causes an X-linked lymphoproliferative syndrome, Nature, vol.101, issue.7115, pp.110-114, 2006.
DOI : 10.1016/S0092-8674(00)80828-4

F. Li, B. Chaigne-delalande, H. Su, G. Uzel, H. Matthews et al., XMEN disease: a new primary immunodeficiency affecting Mg2+ regulation of immunity against Epstein-Barr virus, Blood, vol.123, issue.14, pp.2148-2152, 2014.
DOI : 10.1182/blood-2013-11-538686

K. Izawa, Inherited CD70 deficiency in humans reveals a critical role for the CD70???CD27 pathway in immunity to Epstein-Barr virus infection, The Journal of Experimental Medicine, vol.153, issue.1, pp.73-89, 2017.
DOI : 10.1128/JVI.03305-12

P. Papagiannakis, C. Michalopoulos, F. Papalexi, D. Dalampoura, and M. Diamantidis, The role of Helicobacter pylori infection in hematological disorders, European Journal of Internal Medicine, vol.24, issue.8, pp.685-690, 2013.
DOI : 10.1016/j.ejim.2013.02.011

G. Mameli, Epstein???Barr virus infection is associated to patients with multiple myeloma and monoclonal gammopathy of undetermined significance, Leukemia & Lymphoma, vol.8, issue.2, pp.466-469, 2017.
DOI : 10.1038/sj.onc.1207905

E. Zucca and F. Bertoni, The spectrum of MALT lymphoma at different sites: biological and therapeutic relevance, Blood, vol.127, issue.17, pp.2082-2092, 2016.
DOI : 10.1182/blood-2015-12-624304

R. Küppers, B cells under influence: transformation of B cells by Epstein???Barr virus, Nature Reviews Immunology, vol.3, issue.10, pp.801-812, 2003.
DOI : 10.1038/nri1201

M. Kang and E. Kieff, Epstein???Barr virus latent genes, Experimental & Molecular Medicine, vol.11, issue.1, p.131, 2015.
DOI : 10.1371/journal.pone.0010126

URL : http://www.nature.com/emm/journal/v47/n1/pdf/emm201484a.pdf

N. Sivachandran, F. Sarkari, and L. Frappier, Epstein-Barr Nuclear Antigen 1 Contributes to Nasopharyngeal Carcinoma through Disruption of PML Nuclear Bodies, PLoS Pathogens, vol.4, issue.10, p.1000170, 2008.
DOI : 10.1371/journal.ppat.1000170.s003

URL : https://doi.org/10.1371/journal.ppat.1000170

L. Frappier, Contributions of Epstein???Barr Nuclear Antigen 1 (EBNA1) to Cell Immortalization and Survival, Viruses, vol.106, issue.12, pp.1537-1547, 2012.
DOI : 10.1128/MCB.23.19.6901-6908.2003

URL : http://www.mdpi.com/1999-4915/4/9/1537/pdf

J. Tellam, Targeting of EBNA1 for Rapid Intracellular Degradation Overrides the Inhibitory Effects of the Gly-Ala Repeat Domain and Restores CD8+ T Cell Recognition, Journal of Biological Chemistry, vol.71, issue.36, pp.33353-33360, 2001.
DOI : 10.1016/S1097-2765(00)00074-5

P. Zou, J. Kawada, L. Pesnicak, and J. Cohen, Bortezomib Induces Apoptosis of Epstein-Barr Virus (EBV)-Transformed B Cells and Prolongs Survival of Mice Inoculated with EBV-Transformed B Cells, Journal of Virology, vol.81, issue.18, pp.10029-10036, 2007.
DOI : 10.1128/JVI.02241-06

F. Destro, Proteasome inhibitors induce the presentation of an Epstein-Barr virus nuclear antigen 1-derived cytotoxic T lymphocyte epitope in Burkitt???s lymphoma cells, Immunology, vol.81, issue.1, pp.105-114, 2011.
DOI : 10.1128/JVI.02241-06

K. Hui, B. Lam, D. Ho, S. Tsao, and A. Chiang, Bortezomib and SAHA Synergistically Induce ROS-Driven Caspase-Dependent Apoptosis of Nasopharyngeal Carcinoma and Block Replication of Epstein-Barr Virus, Molecular Cancer Therapeutics, vol.12, issue.5, pp.747-758, 2013.
DOI : 10.1158/1535-7163.MCT-12-0811

S. Nair, A. Branagan, J. Liu, C. Boddupalli, P. Mistry et al., Clonal Immunoglobulin against Lysolipids in the Origin of Myeloma, New England Journal of Medicine, vol.374, issue.6, pp.555-561, 2016.
DOI : 10.1056/NEJMoa1508808

C. Vidal, An HSP90-mimic peptide revealed by fingerprinting the pool of antibodies from ovarian cancer patients, Oncogene, vol.23, issue.55, pp.8859-8867, 2004.
DOI : 10.1054/bjoc.1999.0881

D. Jaalouk, The Original Pathologische Anatomie Leiden-Endothelium Monoclonal Antibody Recognizes a Vascular Endothelial Growth Factor Binding Site within Neuropilin-1, Cancer Research, vol.67, issue.20, pp.9623-9629, 2007.
DOI : 10.1158/0008-5472.CAN-07-2737

M. Cardó-vila, From combinatorial peptide selection to drug prototype (II): Targeting the epidermal growth factor receptor pathway, Proceedings of the National Academy of Sciences, vol.4, issue.5, pp.5118-5123, 2010.
DOI : 10.1002/pmic.200300680

P. Mintz, Discovery and horizontal follow-up of an autoantibody signature in human prostate cancer, Proceedings of the National Academy of Sciences, vol.45, issue.8 Pt 1, pp.2515-2520, 2015.
DOI : 10.1126/science.1696028